Delayed improvement of insulin secretion after autologous islet transplantation in partially pancreatectomized patients

Metabolism: Clinical and Experimental

Volumn 58, Issue 11, 2009, Pages 1629-1635

  Jung, Hye Seung ^a   Choi, Seong Ho ^b   Kim, Sung Joo ^b   Choi, Dong Wook ^b   Heo, Jin Seok ^b   Lee, Kyu Taek ^a   Lee, Jong Kyun ^a   Jang, Kee Taek ^b   Lee, Byung Wan ^a   Jee, Jae Hwan ^a   Noh, Jung Hyun ^a   Jeong, In Kyung ^a   Yang, Tae Young ^a   Oh, Seung Hoon ^a   Ahn, You Ran ^a   Kim, Young Seok ^a   No, Heesung ^a   Lee, Moon Kyu ^a   Kim, Kwang Won ^a  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; MALE; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PANCREAS TUMOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME; AGING; BLOOD; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGING; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS;

EID: 70449732666     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.015     Document Type: Article

References (31)

1. Bertuzzi F., and Ricordi C. Prediction of clinical outcome in islet allotransplantation. Diabetes Care 30 (2007) 410-417
2. Emamaullee J.A., and Shapiro A.M. Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant 16 (2007) 1-8
3. Jung H.S., Choi S.H., Kim S.J., Lee K.T., Lee J.K., Jang K.T., et al. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors. Clin Transplant 21 (2007) 738-743
4. Berney T., Mathe Z., Bucher P., Demuylder-Mischler S., Andres A., Bosco D., et al. Islet autotransplantation for the prevention of surgical diabetes after extended pancreatectomy for the resection of benign tumors of the pancreas. Transplant Proc 36 (2004) 1123-1124
5. Lee B.W., Jee J.H., Heo J.S., Choi S.H., Jang K.T., Noh J.H., et al. The favorable outcome of human islet transplantation in Korea: experiences of 10 autologous transplantations. Transplantation 79 (2005) 1568-1574
6. Lee B.W., Kang H.W., Heo J.S., Choi S.H., Kim S.Y., Min Y.K., et al. Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy. Metabolism 55 (2006) 135-141
7. Frey C.F., Child C.G., and Fry W. Pancreatectomy for chronic pancreatitis. Ann Surg 184 (1976) 403-413
8. Kendall D.M., Sutherland D.E., Najarian J.S., Goetz F.C., and Robertson R.P. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322 (1990) 898-903
9. Menge B.A., Schrader H., Breuer T.G., Dabrowski Y., Uhl W., Schmidt W.E., et al. Metabolic consequences of a 50% partial pancreatectomy in humans. Diabetologia 52 (2009) 306-317
10. Bank H.L. Rapid assessment of islet viability with acridine orange and propidium iodide. In Vitro Cell Dev Biol 24 (1988) 266-273
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
12. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
13. Seltzer H.S., Allen E.W., Herron Jr. A.L., and Brennan M.T. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46 (1967) 323-335
14. Yamada Y., Fukuda K., Fujimoto S., Hosokawa M., Tsukiyama K., Nagashima K., et al. SUIT, secretory units of islets in transplantation: an index for therapeutic management of islet transplanted patients and its application to type 2 diabetes. Diabetes Res Clin Pract 74 (2006) 222-226
15. Brendel M.D., Hering B.J., Schultz A.O., and Bretzel R.G. International Islet Transplant Registry. Newsletter # 9 8 (2001)
16. Robertson R.P., Lanz K.J., Sutherland D.E., and Kendall D.M. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes 50 (2001) 47-50
17. Ryan E.A., Paty B.W., Senior P.A., Bigam D., Alfadhli E., Kneteman N.M., et al. Five-year follow-up after clinical islet transplantation. Diabetes 54 (2005) 2060-2069
18. Sutherland D.E., Gruessner A.C., Carlson A.M., Blondet J.J., Balamurugan A.N., Reigstad K.F., et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation 86 (2008) 1799-1802
19. Hussain M.A., and Theise N.D. Stem-cell therapy for diabetes mellitus. Lancet 364 (2004) 203-205
20. Hamamoto Y., Tsuura Y., Fujimoto S., Nagata M., Takeda T., Mukai E., et al. Recovery of function and mass of endogenous beta-cells in streptozotocin-induced diabetic rats treated with islet transplantation. Biochem Biophys Res Commun 287 (2001) 104-109
21. Jung H.S., Ahn Y.-R., Oh S.-H., Kim Y.-S., No H., Lee M.-K., et al. Enhancement of beta cell regeneration by islet transplantation after partial pancreatectomy in mice. Transplantation (2009) [in press]
22. Bonner-Weir S., Baxter L.A., Schuppin G.T., and Smith F.E. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42 (1993) 1715-1720
23. Leahy J.L., Bonner-Weir S., and Weir G.C. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes 33 (1984) 667-673
24. Peshavaria M., Larmie B.L., Lausier J., Satish B., Habibovic A., Roskens V., et al. Regulation of pancreatic beta-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse. Diabetes 55 (2006) 3289-3298
25. Menge B.A., Tannapfel A., Belyaev O., Drescher R., Muller C., Uhl W., et al. Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes 57 (2008) 142-149
26. Lau J., Jansson L., and Carlsson P.O. Islets transplanted intraportally into the liver are stimulated to insulin and glucagon release exclusively through the hepatic artery. Am J Transplant 6 5 Pt 1 (2006) 967-975
27. Gerich J.E. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 163 (2003) 1306-1316
28. Bhargava R., Senior P.A., Ackerman T.E., Ryan E.A., Paty B.W., Lakey J.R., et al. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 53 (2004) 1311-1317
29. Dombrowski F., Mathieu C., and Evert M. Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats. Cancer Res 66 (2006) 1833-1843
30. Evert M., Schildhaus H.U., Schneider-Stock R., and Dombrowski F. Cystic cholangiomas after transplantation of pancreatic islets into the livers of diabetic rats. Virchows Arch 448 (2006) 776-787
31. Yki-Jarvinen H., Kiviluoto T., and Taskinen M.R. Insulin resistance is a prominent feature of patients with pancreatogenic diabetes. Metabolism 35 (1986) 718-727